The 20 Best Primary Localized Cutaneous Amyloidosis Doctors near Needham, MA

Lisa Fleming is an Internal Medicine specialist and a Transplant Surgeon in Needham, Massachusetts. Dr. Fleming has been practicing medicine for over 18 years and is rated as an Advanced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Edema, Cardiac Ablation, and Pacemaker Implantation.

Rodney Falk is a Cardiologist in Boston,, Massachusetts. Dr. Falk is rated as a Distinguished provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloidosis, Heart Transplant, and Cardiac Ablation.

Omar Siddiqi is a Cardiologist in Boston,, Massachusetts. Dr. Siddiqi is rated as a Distinguished provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Primary Amyloidosis, Cardiac Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Primary Localized Cutaneous Amyloidosis, and Tissue Biopsy.

Joseph Kannam is an Internal Medicine provider in Needham, Massachusetts. Dr. Kannam is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Coronary Heart Disease, Mitral Valve Regurgitation, Angina, Atherosclerosis, and Pacemaker Implantation.

Jessica Haffajee is an Internal Medicine provider in Needham, Massachusetts. Dr. Haffajee is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Aortic Valve Stenosis, Atherosclerosis, Coronary Heart Disease, and Atrial Fibrillation.

Ian Mccormick is an Internal Medicine provider in Needham, Massachusetts. Dr. Mccormick has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Familial Neurocardiogenic Syncope, Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Edema, Heart Failure, and Angioplasty.

Emily Robinson MD is a clinical nephrologist and Instructor in Medicine at Harvard Medical School, as well as the Director of Community Nephrology at BWH.  She sees patients with a variety of renal issues.  Her clinical interests include chronic kidney disease management and prevention, the transition to end stage renal disease, kidney stone prevention, lupus nephritis, as well as working closely with the renal transplant team to do donor evaluations and to follow patients in the community post-transplant. Dr. Robinson is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Boils, and Nephrogenic Diabetes Insipidus.

Brian Mcgeeney is a Neurologist in Jamaica Plain, Massachusetts. Dr. Mcgeeney is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Migraine, Headache, Cluster Headache, and Migraine with Brainstem Aura.

Dr. Raymond Y. Kwong is the director of Cardiac Magnetic Resonance Imaging (MRI) at Brigham and Women’s Hospital (BWH). A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School (HMS).Dr. Kwong received his medical degree from University of Toronto Faculty of Medicine. He completed a residency in internal medicine at Vancouver General Hospital and a fellowship in cardiovascular disease at The George Washington University Hospital. He then completed a cardiac MRI fellowship program at the National Heart, Lung and Blood Institutes of Health. Dr. Kwong is board certified in internal medicine and cardiovascular disease.He has authored over 290 peer-reviewed publications. His clinical interests and research focus on cardiac imaging, specifically the use of cardiac MRI to assess ventricular remodeling after acute myocardial infarction. He has received multiple grants from the National Institutes of Health, American Heart Association, Canadian Institute of Health Research, and the Society for Cardiovascular Magnetic Resonance for his research. Dr. Kwong is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Cardiomyopathy, Cardiac Amyloidosis, Hypertrophic Cardiomyopathy (HCM), Cardiac Ablation, and Heart Transplant.

Milena Pavlova, MD, is a board-certified neurologist with a dual subspecialty certification in Sleep Medicine and Epilepsy. She currently serves as the Medical Director of the BWFH Sleep Testing Center, and is involved in the training of medical students, neurology residents and epilepsy fellows. She has established combined polysomnogram and electroencephalography (EEG) monitoring of patients at the Faulkner Sleep Laboratory to evaluate patients with complex sleep disorders in the setting of neurological and psychiatric conditions and collaboratively lead the establishment of the circadian clinic. She is a recipient of the BWH Distinguished clinician award.Dr. Pavlova’s reads EEGs and sleep tests daily in her clinical work and has lead research activities addressing the interactions between sleep and neurological disorders for more than a decade. Her past research projects have assessed various aspects of sleep and epilepsy with a specific focus on the circadian rhythm effects, publishing some of the first studies on the subject. This work has since been replicated in multiple different epilepsy centers, and further extended to explore the role of sleep and biological rhythms in the pathogenesis of sudden death in epilepsy patients (SUDEP) – the most devastating consequence of epilepsy.Currently, Dr. Pavlova serves as principal investigator on several research studies aiming at optimizing diagnosis using objective EEG criteria. Since hypersomnia is common among patients with depression, and antidepressant medications can affect the results of sleep tests used in the evaluation of hypersomnia (typically a multiple sleep latency test [MSLT]), she currently leads a project that specifically aims at in patients with depression, who are still taking antidepressants at the time of the test. This project established a database of MSLT/sleep/EEG test results from five Harvard-affiliated hospitals, with inclusion of comorbidities and level of sleepiness. This allows more specific analysis of correlation between specific EEG and sleep parameters and depression symptoms of the participants. Dr. Pavlova is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Seizures, Memory Loss, Epilepsy, and Obstructive Sleep Apnea.

Frederick Basilico is an Internal Medicine provider in Boston, Massachusetts. Dr. Basilico is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Atrial Fibrillation, Angina, Arrhythmias, and Coronary Heart Disease.

Scott Mcginnis is a Neurologist in Boston, Massachusetts. Dr. Mcginnis is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Primary Progressive Aphasia, Frontotemporal Dementia, Dementia, Lewy Body Dementia (LBD), and Gastrostomy.

Dr. Thomas Edward Noonan is a cardiovascular medicine specialist at Brigham and Women’s Hospital. In addition, he is an instructor in medicine at Harvard Medical School. He is also a clinical assistant professor of medicine at The Warren Alpert Medical School of Brown University.Dr. Noonan received his medical degree from Pennsylvania State Hershey College of Medicine. He completed an internal medicine residency at Beth Israel Deaconess Medical Center and a cardiology fellowship at Boston Medical Center. He is board certified in internal medicine and cardiovascular disease.The author of more than four peer-reviewed publications, Dr. Noonan’s research focuses on cardiomyopathy and coronary stenosis. Dr. Noonan’s clinical interests include adult cardiology, cardiac catheterization, and echocardiography. Rhode Island Monthly has listed him as a Top Doctor/Cardiology. Dr. Noonan is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Angina, Coronary Heart Disease, Atherosclerosis, Dilated Cardiomyopathy (DCM), and Pacemaker Implantation.

Dr. Usha B. Tedrow is director of the Clinical Cardiac Electrophysiology Program at Brigham and Women’s Hospital’s (BWH) Heart Rhythm Program. A cardiovascular medicine specialist, she is also an assistant professor of medicine at Harvard Medical School (HMS).Dr. Tedrow received her medical degree from HMS. She completed an internal medicine residency and a cardiology fellowship at Massachusetts General Hospital. In addition, she completed a cardiac electrophysiology fellowship at BWH. Dr. Tedrow is board certified in internal medicine, cardiovascular disease and cardiac electrophysiology.Her clinical interests include atrial fibrillation, cardiac resynchronization and ventricular tachycardia. She is currently researching left ventricular mapping and pacing data to analyze novel ablation treatments for structural heart disease. In addition, Dr. Tedrow serves on the editorial board of Circulation: Arrhythmia and Electrophysiology, has authored over 120 peer-reviewed publications and has received research funding from the Heart Rhythm Society. Dr. Tedrow is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Ventricular Tachycardia, Arrhythmias, Paroxysmal Supraventricular Tachycardia (PSVT), Cardiac Ablation, and Pacemaker Implantation.

Patrick T. O'Gara, MD, is the Director of Strategic Planning for the Cardiovascular Division at Brigham and Women’s Hospital, the Watkins Family Distinguished Chair in Cardiology and Professor of Medicine at Harvard Medical School. His clinical activities are focused on patients with valvular heart disease, other structural heart diseases and aortic diseases, although he also maintains a large practice of general cardiology. Since 2001, he has been named annually among the Top Doctors in Boston and the U.S.O'Gara served as President of the American College of Cardiology (ACC) in 2014-15. Additional ACC leadership positions include his roles as Co-Chair of the ACC 2012 Scientific Session program committee, co-directorship of the ACC Board Review Course for Certification and Recertification, and Editor-in-Chief of the ACC Self-Assessment Program (ACCSAP). He served as Chair of the American Heart Association's (AHA's) Council on Clinical Cardiology from 2003-2005 and as the inaugural Editor of Heart Insight magazine from 2006 to 2011. In 2011, he received the Paul Dudley White Award from the Boston Division of the AHA Founder's Affiliate and has also been recognized with the Laennec Master Clinician Award (2011) and the Laennec Clinician Educator Award (2012). O'Gara was Chair of the writing committee for the 2013 ACC/AHA Guideline for the Management of Patients with ST-Elevation MI and has participated in several other guideline, expert consensus, scientific advisory and appropriate use criteria writing groups.He is currently the Vice-Chair for the AHA/ACC Task Force on Clinical Practice Guidelines. He is also the Steering Committee Co-Chair of the National Heart, Lung, and Blood Institute's Cardiothoracic Surgery Network, which has completed 3 groundbreaking, randomized controlled trials in cardiac surgery. O’Gara serves as Associate Editor for JAMA Cardiology and is a member of the Editorial Boards of the Journal of the American College of Cardiology and Circulation. He has lectured widely and authored or co-authored over 250 original manuscripts, chapters, critical reviews, statements and editorials. Dr. O'gara is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Bicuspid Aortic Valve, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an Associate Professor of Medicine at Harvard Medical School (HMS).Dr. Nohria received her medical degree from HMS. She completed an internal medicine residency and was a chief resident at Yale-New Haven Hospital. She then completed both a cardiovascular medicine fellowship and a heart failure and transplantation fellowship at BWH. She is board certified in cardiovascular disease and heart failure and transplantation.Dr. Nohria’s clinical interests include cardio-oncology and heart failure and transplantation. The author of over 100 peer-reviewed publications, she currently researches how to evaluate, prevent and treat cardiovascular complications that can arise as a consequence of cancer therapy. Dr. Nohria is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Myocarditis, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

Dr. Garrick C. Stewart is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and an instructor in medicine at Harvard Medical School. In addition, he is director of Care New England’s Advanced Heart Failure Program as part of the BWH Cardiovascular Associates at Kent Hospital in Rhode Island.Dr. Stewart received his medical degree from The Johns Hopkins University School of Medicine. He completed his internal medicine residency at BWH; he also completed fellowships in cardiovascular medicine and advanced heart failure at BWH. Dr. Stewart is board certified in advanced heart failure and transplant cardiology, internal medicine and cardiovascular disease.The author of 30 peer-reviewed publications, Dr. Stewart’s research focuses on the physiology of advanced cardiac disease, including inflammatory heart disease, cardiac sarcoidosis and ambulatory advanced heart failure. In collaboration with Dr. Lynne W. Stevenson, he designed and launched the Medical Arm of Mechanically Assisted Circulatory Support (also known as MedaMACS), a nationwide registry of medically managed, ambulatory advanced heart failure patients. Dr. Stewart is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Sarcoidosis, Heart Failure, Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

Dr. Neal K. Lakdawala is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an instructor in medicine at Harvard Medical School (HMS).Dr. Lakdawala received his medical degree from The University of Texas HSCSA. He completed a residency and chief residency in internal medicine at Columbia-Presbyterian Medical Center, a clinical and research fellowship in cardiovascular disease at BWH and a master’s degree in epidemiology at the Harvard School of Public Health. Dr. Lakdawala is board certified in internal medicine, cardiovascular disease and advanced heart failure and transplant cardiology.His clinical expertise includes cardiomyopathy, cardiac sarcoidosis, congestive heart failure, cardiovascular genetics and heart transplantation. Dr. Lakdawala’s research and peer-reviewed publications investigate early phenotypes in genetic cardiomyopathy to identify physiology-based therapeutics for heart failure. He has received research funding from the National Institutes of Health’s Heart Failure Network. Dr. Lakdawala is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Familial Hypertrophic Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

Dr. Sun is a clinician educator with a focus in valvular heart disease and echocardiography.   He has a particular interest and expertise in structural echocardiography for the pre and peri-procedural  evaluation  of percutaneous  valvular procedures  (including transcatheter  aortic valve replacement,  percutaneous  mitral valve repair and left atrial appendage closure).  In addition to his clinical activities, he is dedicated to the clinical education of medical students, residents and fellows.  He was chosen to be a chief medical resident at Brigham and Women's Hospital and spent the year dedicated to teaching the house staff.  As an instructor in medicine within the cardiology division at Columbia University Medical Center, he has been invited to lecture both the house staff and fellows several times.  He also served as an informal mentor for several fellows during this time helping with career guidance and also in challenging clinical cases. Dr. Sun is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Mitral Valve Regurgitation, Pulmonary Veno-Occlusive Disease, Pulmonary Hypertension, Pacemaker Implantation, and Cardiac Ablation.

Dr. Paul Zei is a Cardiac Electrophysiologist and Cardiologist at Brigham and Women’s Hospital. He is Director of the BWH Comprehensive Atrial Fibrillation Program, with a faculty appointment at Harvard Medical School.Dr. Zei earned his medical degree and a PhD at Stanford University. He then completed Internal Medicine Internship and Residency, Cardiology Fellowship, and Cardiac Electrophysiology Fellowship training at BWH. After briefly serving on the faculty at BWH, he moved to Stanford University, where he spent eleven years as a faculty member in Cardiology and Cardiac Electrophysiology. At Stanford, Dr. Zei developed a program in complex ablation, a research program in technology innovation, and he also served as the Director of Outpatient Cardiology and ECG services. Dr. Zei then returned to Boston to re-join the faculty at BWH and Harvard Medical School.Dr. Zei’s clinical interests focus on management of complex arrhythmias, with an emphasis on atrial fibrillation, catheter ablation of complex arrhythmias, and device implantation. In his role as Director of BWH’s Comprehensive Atrial Fibrillation Program, Dr. Zei brings together a multi-disciplinary approach to the management of patients with Atrial Fibrillation and leads several research initiatives to better understand and treat patients with this condition. Dr. Zei’s research interests are in understanding the basic underlying mechanisms of cardiac arrhythmias and developing new technologies to treat patients with cardiac arrhythmias. Dr. Zei is rated as an Experienced provider by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. His top areas of expertise are Atrial Fibrillation, Ventricular Tachycardia, Arrhythmias, Cardiac Ablation, and Pacemaker Implantation.